Medivolve Inc. (MEDVF)
OTC
Healthcare
Medical - Diagnostics & Research
$0.00
▲ +0.00%
Market Cap
$2,702
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
2.73
52-Wk Range
0.0001-0.002
CEO
Neil Said
Country
CA
Currency
USD
Medivolve Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,702. On trailing twelve-month figures it carries a trailing P/E of -0.21, a net margin of -2397.5%. Its beta of 2.73 implies it has historically moved more than the broad market.
Valuation & profitability (TTM)
P/E
-0.21
Price / Sales
1.18
Price / Book
-0.05
EV / EBITDA
-0.61
Gross margin
78.3%
Operating margin
-521.5%
Net margin
-2397.5%
Return on equity
—
Debt / equity
-0.11
Current ratio
0.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
25
IPO date
2009-12-18
Headquarters
Toronto, ON, CA
About Medivolve Inc.
Medivolve Inc. is a primary investment firm headquartered in Toronto, Canada. Established in 2005, this company, formerly known as QuestCap Inc., channels its investments predominantly into healthcare technology, industrial enterprises, and information technology.
Comparable companies
Medivolve Inc. is most often compared with the following Healthcare names:
More research on MEDVF
Open full interactive analysis & DCF →